腹腔镜与开腹全胃切除术治疗胃腺癌的短期和长期生存比较:一项国家数据库研究
该研究基于美国国家癌症数据库(2010-2014)分析2584例胃腺癌全胃切除术病例,比较腹腔镜与开腹手术的结局。结果显示,各分期中两种术式的调整30天死亡率、90天死亡率和5年生存率均无显著差异(LTG vs OTG死亡HR 0.89,p=0.20)。
要点
- 腹腔镜与开腹全胃切除术的30天和90天死亡率在各分期均无差异。
- 两种术式的5年生存曲线在各分期均无显著差异。
- 腹腔镜全胃切除术的死亡风险比与开腹手术相似(HR 0.89,p=0.20)。
核心结论
- 腹腔镜与开腹全胃切除术治疗胃腺癌的30天死亡率、90天死亡率和长期生存具有可比性。
研究设计与样本
- 基于美国国家癌症数据库(2010-2014)的回顾性队列研究,共分析2584例胃腺癌全胃切除术病例。
- 病例按分期分层:I期592例(22.9%),II期710例(27.5%),III期1282例(49.6%)。
- 腹腔镜与开腹手术的分布:I期156例(26.4%)vs 436例(73.6%),II期163例(23.0%)vs 547例(77.0%),III期241例(18.8%)vs 1041例(81.2%)。
- 主要结局指标包括30天死亡率、90天死亡率和Kaplan-Meier长期生存曲线。
主要发现
- 调整后30天死亡率在腹腔镜与开腹组间无差异:I期AOR 0.52(p=0.75),II期AOR 1.36(p>0.99),III期AOR 0.46(p=0.29)。
- 调整后90天死亡率无差异:I期AOR 0.46(p=0.99),II期AOR 1.17(p=0.99),III期AOR 0.57(p=0.29)。
- 5年Kaplan-Meier估计生存曲线在两种术式间无差异:I期p=0.20,II期p=0.83,III期p=0.46。
- 腹腔镜组与开腹组相比,死亡风险比相似(HR 0.89,p=0.20)。
临床怎么用
- 对于胃腺癌全胃切除术,腹腔镜入路在短期死亡率和长期生存方面与开腹手术相当,可作为合理选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of laparoscopic total gastrectomy for gastric cancer remains controversial. Our objective was to compare outcomes of laparoscopic total gastrectomy (LTG) vs. open total gastrectomy (OTG) for gastric adenocarcinoma using a national cancer database. METHODS: The National Cancer Database (2010-2014) was analyzed for total gastrectomy cases performed for gastric adenocarcinoma. Patient demographics and surgical outcomes were stratified by stage and compared based on laparoscopic vs. open surgical approach. Primary outcome measures included 30-day and 90-day mortality and Kaplan-Meier curves to estimate long-term survival. RESULTS: There were 2584 cases analyzed, including 592 (22.9%) stage I, 710 (27.5%) stage II, and 1282 (49.6%) stage III cases. The distribution of LTG vs. OTG cases was 156 (26.4%) vs. 436 (73.6%) for stage I, 163 (23.0%) vs. 547 (77.0%) for stage II, and 241 (18.8%) vs. 1041 (81.2%) for stage III. For all stages analyzed, there was no difference between laparoscopic vs. open approach for adjusted 30-day mortality (stage I: adjusted odds ratio (AOR) 0.52, p = 0.75; stage II: AOR 1.36, p > 0.99; stage III: AOR 0.46, p = 0.29) or 90-day mortality (stage I: AOR 0.46, p = 0.99; stage II: AOR 1.17, p = 0.99; stage III: 0.57, p = 0.29). There was no difference between LTG vs. OTG 5-year Kaplan-Meier estimated survival curves for any stage (stage I: p = 0.20; stage II: p = 0.83; stage III: p = 0.46). When compared to OTG, LTG had a similar hazard ratio (HR) for mortality (HR 0.89 p = 0.20). CONCLUSIONS: Laparoscopic total gastrectomy and OTG have comparable 30-day mortality, 90-day mortality, and long-term survival.
引用
- Gambhir S, Inaba CS, Whealon M, et al. Short- and long-term survival after laparoscopic versus open total gastrectomy for gastric adenocarcinoma: a National database study. Surg Endosc. 2020. PMID: 32394166. doi:10.1007/s00464-020-07591-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。